At a glance
- Originator Novartis
- Class Antihypertensives; Phosphonic acids; Tetrazoles
- Mechanism of Action Endopeptidase inhibitors; Endothelin-converting enzyme 1 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cerebral vasospasm; Heart failure; Hypertension